<DOC>
	<DOCNO>NCT00846989</DOCNO>
	<brief_summary>This purpose study access efficacy , tolerability safety RKI983 ( 0.05 % 0.10 % ) ophthalmic solution bid versus daily latanoprost 0.005 % , patient POAG ocular hypertension .</brief_summary>
	<brief_title>Efficacy , Tolerability Safety RKI983 ( 0.05 % &amp; 0.10 % ) v Xalatan Patients With POAG Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<criteria>Females must postmenopausal surgically sterile , must use concomitantly two acceptable form effective contraception Clinical diagnosis POAG OH For study eye previously treat antiglaucoma medication IOP must ≥ 22 mm Hg least two assessment timepoints Screening , IOP must ≥ 22 mm Hg least two assessment timepoints Baseline , IOP must ≥ 20 mm Hg ≤ 36 mm Hg Screening Baseline assessment timepoints . Or study eye previously treat antiglaucoma medication IOP must ≥ 14 mm Hg ≤ 24 mm Hg least two assessment timepoints Screening . IOP must ≥ 22 mm Hg least two assessment timepoints Baseline ( washout ) IOP must ≥ 20 mm Hg ≤ 36 mm Hg Baseline assessment timepoints History current clinically significant ocular condition either eye would contraindicate use investigational drug latanoprost ( e.g . active intraocular inflammation ) , might affect interpretation result study . History presence clinically significant medical problem contraindicate use investigational drug latanoprost , include limited : Uncontrolled hypertension systolic blood pressure ≥ 160 mm Hg and/or diastolic blood pressure ≥ 100 mm Hg measure one blood pressure read Screening Baseline ; myocardial infarction within 3 month period prior randomization ; active severe viral infection active encephalitis , meningitis , hepatitis , herpes simplex , herpes zoster ( minor viral upper respiratory infection colds require exclusion . ) Presence moderate severe ( grade 2 3 ) conjunctival hyperemia study eye Baseline Visit . Argon laser trabeculoplasty prior IOP lower surgery study eye . Ocular surgery study eye within 3 month prior Screening Visit . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>glaucoma ,</keyword>
	<keyword>primary open-angle glaucoma ( POAG ) ,</keyword>
	<keyword>ocular hypertension ( OH ) ,</keyword>
	<keyword>intraocular pressure ( IOP )</keyword>
</DOC>